stella
beta
Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors — Stella
Recruiting
Back to Malignant Solid Tumors trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Peking University Cancer Hospital & Institute, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov